NCT05466578Available不适用
Pre-approval Single-patient Expanded Access for Abrocitinib (PF-04965842)
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- Available
- 发起方
- Pfizer
研究概览
简要总结
Provide pre-approval single patient Expanded Access (compassionate use) of abrocitinib for patients with severe uncontrolled atopic dermatitis
详细描述
In Expanded Access, treating physicians are the Sponsor.
Expanded Access requests from treating physicians may be submitted at www.pfizercares.com ; availability will depend on location/country.
研究设计
- 研究类型
- Expanded Access
入排标准
- 年龄范围
- 12 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
Available
不适用
Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)Alopecia AreataNCT05522556Pfizer
No Longer Available
不适用
Pre-approval Single-patient Expanded Access for Elranatamab (PF-06863135)Multiple MyelomaNCT05238311Pfizer
Available
不适用
Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)Metastatic Castration-Resistant Prostate CancerNCT05650476Pfizer
Available
不适用
Provide Pre-approval Single Patient Expanded Access (Compassionate Use) of Etrasimod for Patients.Colitis, UlcerativeNCT06025227Pfizer
No Longer Available
不适用
Provide Pre-approval Single-patient Expanded Access (Compassionate Use) of VYD222 for Patients With Symptomatic COVID-19 Refractory to Other TreatmentsCOVID-19NCT06004128Invivyd, Inc.